ClinConnect ClinConnect Logo
Search / Trial NCT05432453

The Relationship Between Functional Constipation and Sacroiliac Joint Dysfunction

Launched by ABANT IZZET BAYSAL UNIVERSITY · Jun 21, 2022

Trial Information

Current as of July 25, 2025

Recruiting

Keywords

Constipation Women Rehabilitation

ClinConnect Summary

This clinical trial is looking at the connection between chronic constipation and problems with the sacroiliac joint, which is located in the lower back and connects the spine to the pelvis. Researchers want to understand if women who experience functional constipation—constipation that doesn't have a clear medical cause—have more issues with their sacroiliac joint compared to women who do not have constipation.

To participate, women aged between 65 and 74 who meet the criteria for functional constipation can join the study, as long as they haven't used laxatives in the past four weeks. There is also a control group for women who do not have constipation. Participants will help researchers learn more about this relationship, which could lead to better treatments for those affected by chronic constipation. It's important to note that certain conditions, like pregnancy, some medications, and a variety of medical issues, would exclude someone from participating in the trial.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria (for functional constipation group):
  • Voluntary participation in the research
  • Fulfill the diagnostic criteria for functional constipation (Rome IV)
  • Being women
  • Not using laxatives for at least the last 4 weeks
  • Inclusion Criteria (for control group):
  • Voluntary participation in the research
  • Being women
  • Not having functional constipation
  • Exclusion Criteria:
  • Having cooperation problems
  • Being pregnant
  • Being breast-feeding
  • Taking medication for depression, hypertension, sleep disorders, and pain
  • Having parkinson, stroke, spinal cord injury, multiple sclerosis, hypothyroidism, Diabetes Mellitus, cerebral Palsy, thyroid problems, cancer, presence of tumor, presence of hernia, endometriosis, neuropathy, myopathy, scleroderma, inflammatory bowel diseases (Crohn, gastrointestinal tuberculosis, celiac, colon diverticulum, colonoscopy), cognitive impairment
  • Having neurological or metabolic or malignant disorders
  • Having a history of open abdominal surgery
  • Having a history of pelvic and abdominal radiotherapy

About Abant Izzet Baysal University

Abant Izzet Baysal University is a prominent academic institution located in Turkey, dedicated to advancing education, research, and innovation in various fields, including healthcare and clinical studies. The university actively engages in clinical trials to contribute to medical knowledge and improve patient care, leveraging its robust infrastructure and expert faculty. With a commitment to ethical research practices and collaboration with healthcare professionals, Abant Izzet Baysal University aims to enhance the understanding of diseases and develop effective therapeutic interventions, fostering a strong link between academia and clinical application.

Locations

Bolu, , Turkey

Patients applied

0 patients applied

Trial Officials

Ömer Osman Pala

Principal Investigator

Bolu Abant İzzet Baysal University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials